Please check your internet connection and try again.
# Ecospirin (Aspirin, Enteric-Coated)
## Overview
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) and antiplatelet agent. The enteric coating delays disintegration and absorption until the drug reaches the small intestine, which may reduce gastric irritation.
## Primary Indications
* **Cardioprotection:** Prevention of myocardial infarction (MI) and stroke in patients with established cardiovascular disease, or risk factors for cardiovascular disease.
* **Secondary Prevention:** Prevention of recurrent MI, stroke, or cardiovascular death after an initial event.
* **Post-Procedural:** Prevention of thrombosis after coronary artery bypass graft (CABG) surgery, percutaneous coronary intervention (PCI), or in patients with peripheral artery disease.
## Adult Dosing
* **Cardioprotection/Secondary Prevention:** Common doses range from 75 mg to 325 mg once daily. Specific dose selection may depend on local guidelines and individual patient factors.
* **Post-Procedural:** Dosing varies by procedure; often initiated at 75 mg to 325 mg daily, sometimes in combination with other antiplatelet agents. Follow specific institutional protocols.
## Pediatric Dosing
Aspirin is generally *not* recommended for use in children and adolescents due to the risk of Reye's syndrome, particularly during viral illnesses. Specific indications and dosing in pediatrics require expert consultation and are highly specialized, often reserved for Kawasaki disease or rheumatologic conditions under strict monitoring.
## Dose Adjustments
* **Renal Impairment:** Use with caution. Dose reduction may be necessary in severe renal impairment, though specific guidelines are lacking.
* **Hepatic Impairment:** Use with caution. Dose reduction may be considered in severe hepatic impairment, but specific guidelines are lacking.
## Contraindications
* Known hypersensitivity to aspirin, salicylates, or NSAIDs.
* Active peptic ulceration or gastrointestinal bleeding.
* History of bronchospasm, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
* In individuals with hemophilia, thrombocytopenia, or other bleeding disorders.
* Children and adolescents with viral infections (risk of Reye's syndrome).
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, vomiting, abdominal pain, GI bleeding, ulceration.
* **Hematologic:** Increased bleeding risk (ecchymosis, epistaxis, petechiae), prolongation of bleeding time.
* **Hypersensitivity:** Bronchospasm, rash, urticaria, angioedema.
* **Other:** Tinnitus, dizziness, headache.
## Key Drug Interactions
* **Anticoagulants and other Antiplatelets (e.g., warfarin, clopidogrel, heparin, DOACs):** Increased risk of bleeding.
* **NSAIDs (including COX-2 inhibitors):** Increased risk of GI toxicity and potentially reduced cardioprotective effect of aspirin. Concurrent use generally not recommended unless specifically indicated and managed.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, diuretics):** NSAIDs can reduce the efficacy of these medications and may increase the risk of renal dysfunction.
* **Methotrexate:** Aspirin can increase methotrexate toxicity by reducing its renal clearance.
* **Uricosuric agents (e.g., probenecid):** Aspirin can inhibit the uricosuric effect.
* **Alcohol:** Increased risk of GI bleeding.
## Monitoring
* **Bleeding:** Monitor for signs and symptoms of GI bleeding (melena, hematemesis, abdominal pain) and other bleeding (easy bruising, prolonged bleeding from cuts).
* **Renal Function:** Monitor renal function, especially in patients with pre-existing renal disease or those receiving concomitant nephrotoxic agents.
* **Tinnitus:** Can be an early sign of salicylate toxicity.
## Clinical Pearls
* Enteric coating aids in reducing gastric irritation but does not eliminate the risk of GI bleeding or ulceration.
* Aspirin should be swallowed whole and not crushed, chewed, or broken to maintain the integrity of the enteric coating.
* Discontinuation of aspirin should be carefully considered, especially for secondary prevention, as the risk of thrombotic events may increase upon cessation. Consult with a healthcare provider before stopping.
* The cardioprotective dose of aspirin is generally low (75-100 mg), but higher doses (e.g., 325 mg) may be used for acute indications or specific post-procedural regimens.
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.
